NCT00299338View on ClinicalTrials.gov

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

September 30, 2001

Conditions
HIV Infections
Interventions
DRUG

SP01A

Trial Locations (1)

90069

AIDS Research Alliance of West Hollywood, West Hollywood

All Listed Sponsors
lead

Samaritan Pharmaceuticals, Inc

INDUSTRY

NCT00299338 - A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients | Biotech Hunter | Biotech Hunter